Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for methylene root_names_name in Any Name (approximate match)

Showing 101 - 110 of 2117 results

First page
Previous page
Next page
Next page

NIFURDAZIL

W59YJ895ZC

Search for Structure

Status:

Investigational

Source:

INN:nifurdazil

Source URL:

https://tripod.nih.gov/npc/#Download

Class (Stereo):

CHEMICAL (ACHIRAL)

Nifurdazil, a 5-nitrofuran derivative, ia an antibacterial agent.

LIGHT GREEN CF YELLOWISH

K414AX1M5S

Search for Structure

Status:

Excipient

Source:

Source URL:

https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L

Class (Stereo):

CHEMICAL (ACHIRAL)

DSP-5336

VW83Y2JLZ5

Search for Structure

Status:

Designated

Source:

FDA ORPHAN DRUG:887822

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/VW83Y2JLZ5

Class (Stereo):

CHEMICAL (ABSOLUTE)

5,5-(4-(TRIFLUROMETHYL)BENZYLAZANEDIYL)BIS(METHYLENE)DIQUINOLIN-8-OL

8KG95Q2DQH

Search for Structure

Status:

Designated

Source:

EU-Orphan Drug:EU/3/14/1408

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/8KG95Q2DQH

Class (Stereo):

CHEMICAL (ACHIRAL)

N'-(5-CHLORO-2-HYDROXY-3-METHYLBENZYLIDENE)-2,4-DIHYDROXYBENZHYDRAZIDE

62DD8FF6GM

Search for Structure

Status:

Designated

Source:

EU-Orphan Drug:EU/3/08/568

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/62DD8FF6GM

Class (Stereo):

CHEMICAL (ACHIRAL)

U-0126

8027P94HLL

Search for Structure

Status:

Designated

Source:

EU-Orphan Drug:EU/3/17/1935

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/8027P94HLL

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

Dual specificity mitogen-activated protein kinase kinase 2

Dual specificity mitogen-activated protein kinase kinase 1

U0126 is a highly selective inhibitor of both MEK1 and MEK2, a type of MAPK/ERK kinase. The inhibitory effects of U0126 on MEK and ERK activation have been confirmed repeatedly, and treatments with U0126 have been shown to inhibit proliferation and migration of cancer cells in vivo and in vitro. U0126 has been widely used as an inhibitor for the Ras/Raf/MEK/ERK signaling pathway. U0126 treatments lead to cancer cell death, which agrees with the well-known role of the Ras/Raf/MEK/ERK pathway in supporting cell survival. U0126 enhances apoptosis in human breast cancer MCF-7 cells, acute myeloid leukemia, and PC12 cells.

1,3-Diethyl 2-[(2,5-dimethoxyphenyl)methylene]propanedioate

26J2P375DA

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

(4,4'-Bis(4-cyanophenoxy)-[1,1'-biphenyl]-2,2'-diyl)bis(methylene)diacetate

JU47WW5CYV

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

Disperse Blue 87

9NVN8M73TB

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

Lexidronam dicalcium

LTG4744QEH

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

Structure of NIFURDAZIL

ACHIRAL

Structure of LIGHT GREEN CF YELLOWISH

ACHIRAL

LIGHT GREEN CF YELLOWISH

Structure of DSP-5336

ABSOLUTE

Structure of 5,5-(4-(TRIFLUROMETHYL)BENZYLAZANEDIYL)BIS(METHYLENE)DIQUINOLIN-8-OL

ACHIRAL

5,5-(4-(TRIFLUROMETHYL)BENZYLAZANEDIYL)BIS(METHYLENE)DIQUINOLIN-8-OL

Structure of N'-(5-CHLORO-2-HYDROXY-3-METHYLBENZYLIDENE)-2,4-DIHYDROXYBENZHYDRAZIDE

ACHIRAL

N'-(5-CHLORO-2-HYDROXY-3-METHYLBENZYLIDENE)-2,4-DIHYDROXYBENZHYDRAZIDE

Structure of U-0126

ACHIRAL

Structure of 1,3-Diethyl 2-[(2,5-dimethoxyphenyl)methylene]propanedioate

ACHIRAL

1,3-Diethyl 2-[(2,5-dimethoxyphenyl)methylene]propanedioate

Structure of (4,4'-Bis(4-cyanophenoxy)-[1,1'-biphenyl]-2,2'-diyl)bis(methylene)diacetate

ACHIRAL

(4,4'-Bis(4-cyanophenoxy)-[1,1'-biphenyl]-2,2'-diyl)bis(methylene)diacetate

Structure of Disperse Blue 87

ACHIRAL

Disperse Blue 87

Structure of Lexidronam dicalcium

ACHIRAL

Lexidronam dicalcium

Showing 101 - 110 of 2117 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1